Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of TAK-233 in healthy Japanese women
jRCT2080222396Phase 1
- Sponsor
- Takeda
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of TAK-233 (2 arms), sponsored by Takeda.
02
Drugs
TAK-233
Beyond the preview
Go deeper on jRCT2080222396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222396.